Cardinal Health, Inc. $CAH Shares Sold by Focus Partners Wealth

Focus Partners Wealth trimmed its position in shares of Cardinal Health, Inc. (NYSE:CAH) by 11.0% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 328,437 shares of the company’s stock after selling 40,639 shares during the quarter. Focus Partners Wealth owned approximately 0.14% of Cardinal Health worth $67,224,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in CAH. Nordea Investment Management AB lifted its position in Cardinal Health by 328.3% during the fourth quarter. Nordea Investment Management AB now owns 645,436 shares of the company’s stock worth $133,741,000 after buying an additional 494,731 shares during the period. Victory Capital Management Inc. lifted its position in Cardinal Health by 44.9% during the third quarter. Victory Capital Management Inc. now owns 2,284,115 shares of the company’s stock worth $352,165,000 after buying an additional 707,495 shares during the period. Procyon Advisors LLC lifted its position in Cardinal Health by 78.7% during the fourth quarter. Procyon Advisors LLC now owns 17,025 shares of the company’s stock worth $3,499,000 after buying an additional 7,499 shares during the period. Public Sector Pension Investment Board lifted its position in Cardinal Health by 66.7% during the third quarter. Public Sector Pension Investment Board now owns 30,007 shares of the company’s stock worth $4,710,000 after buying an additional 12,003 shares during the period. Finally, Sierra Summit Advisors LLC purchased a new position in Cardinal Health during the third quarter worth about $9,897,000. 87.17% of the stock is currently owned by hedge funds and other institutional investors.

Cardinal Health Stock Performance

CAH stock opened at $226.52 on Tuesday. Cardinal Health, Inc. has a 1 year low of $137.75 and a 1 year high of $233.60. The firm has a market cap of $53.05 billion, a P/E ratio of 34.64, a price-to-earnings-growth ratio of 1.22 and a beta of 0.52. The stock has a 50-day simple moving average of $203.46 and a 200-day simple moving average of $208.92.

Cardinal Health (NYSE:CAH) last posted its earnings results on Thursday, April 30th. The company reported $3.17 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.79 by $0.38. Cardinal Health had a negative return on equity of 92.61% and a net margin of 0.62%.The business had revenue of $60.94 billion during the quarter, compared to analyst estimates of $62.10 billion. During the same quarter last year, the firm earned $2.35 earnings per share. The company’s revenue for the quarter was up 11.0% compared to the same quarter last year. Cardinal Health has set its FY 2026 guidance at 10.700-10.80 EPS. On average, equities research analysts predict that Cardinal Health, Inc. will post 10.76 EPS for the current year.

Cardinal Health Increases Dividend

The business also recently announced a quarterly dividend, which will be paid on Wednesday, July 15th. Stockholders of record on Wednesday, July 1st will be paid a $0.5158 dividend. This represents a $2.06 dividend on an annualized basis and a dividend yield of 0.9%. This is an increase from Cardinal Health’s previous quarterly dividend of $0.51. The ex-dividend date is Wednesday, July 1st. Cardinal Health’s payout ratio is 31.19%.

Analysts Set New Price Targets

CAH has been the topic of several recent analyst reports. Citigroup reduced their target price on Cardinal Health from $249.00 to $245.00 and set a “buy” rating on the stock in a research report on Friday, May 1st. Robert W. Baird set a $248.00 target price on Cardinal Health in a research report on Friday, May 1st. Barclays increased their target price on Cardinal Health from $243.00 to $258.00 and gave the stock an “overweight” rating in a research report on Tuesday, February 24th. Evercore reduced their target price on Cardinal Health from $260.00 to $240.00 and set an “outperform” rating on the stock in a research report on Wednesday, April 8th. Finally, Wall Street Zen downgraded Cardinal Health from a “strong-buy” rating to a “buy” rating in a research report on Monday. One analyst has rated the stock with a Strong Buy rating, fourteen have assigned a Buy rating and two have given a Hold rating to the company. Based on data from MarketBeat, Cardinal Health presently has a consensus rating of “Moderate Buy” and a consensus price target of $246.93.

About Cardinal Health

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.